InvestorsHub Logo
Followers 3
Posts 3175
Boards Moderated 0
Alias Born 09/03/2007

Re: None

Monday, 06/30/2008 11:59:12 PM

Monday, June 30, 2008 11:59:12 PM

Post# of 589242
TCLT,,Hey $treet,,PR


TCLT PR !!!!!!!!!! Techalt, Inc. Announces Stan's Rodeo Ointment to be Exclusively Compounded by HNP Pharmaceuticals

Techalt, Inc. (Pink Sheets: TCLT) ("Techalt" or "Company") announced that HNP Pharmaceuticals (“HNP”), has agreed to exclusively compound Stan’s Rodeo Ointment (“SRO”). HNP is a pharmaceutical compounding laboratory that compounds medications dispensed by prescription. Sportpharm, a subsidiary of HNP Pharmaceuticals, fulfills the needs of athletes and sports organizations to include professional teams, collegiate and Olympic training centers nationwide.

Techalt is currently in the process of securing financing for expanding SRO’s distribution channels, which includes securing significant contracts obtaining over the counter approval from the Food and Drug Administration.

About HNP Pharmaceuticals (“HNP”): HNP Pharmaceuticals is a nationally recognized pharmaceutical compounding laboratory, specializing in unique and patent-pending compounded formulations for orthopedic injuries. HNP is the primary compounding pharmacy for more than 70% of all professional athletes in the United States, the Olympics, and an ever-growing number of collegiate sports programs.

About Stan’s Rodeo Ointment (“SRO”): SRO is a sports cream product designed to accelerate the healing time for abrasions, lacerations, blisters and other open wounds to the skin, while diminishing the pain that often results from such injuries. Developed by Stanley Johnston, former head athletic trainer for the Los Angeles Dodgers, SRO is currently available by prescription and used by several prominent Olympic and professional athletes. Techalt also acquired the rights to develop Stan’s Blister Rub (“SBR”), which is a combination of materials that strengthen the skin after it has healed to reduce the likelihood of the reoccurrence of blisters to the applied area. Patent protection has been filed covering the formulations and processing of SRO with the US Patent and Trademark Office with a patent expected in August 2008.

About Techalt: Techalt’s business model as a public holding company is to pursue quality opportunities in developing early to mid-stage alternative technology, communications, environmental and health and wellness companies.

Forward-Looking Statements This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended ("the Exchange Act"), as such, may involve risks and uncertainties. Forward-looking statements are based upon certain assumptions and describe future plans, strategies and expectations, are generally identifiable by the use of words as "believe," "expect," "intend," "anticipate," "project," or other similar expressions. Forward-looking statements relate to, among other things, future performance, and perceived opportunities in the market and statements regarding the Company's mission and vision. The Company's actual results, performance and achievements may differ materially from the results, performance, and achievements expressed or implied in such forward-looking statements. Additional factors could materially affect these forward-looking statements and/or predictions include, among other things: (1) managing acquisitions and expansion of operations; (2) obtaining necessary financing and managing existing debt; (3) completing the investigation, acquisition and integration of new business opportunities; (4) complying with federal, state and local government and international regulations; and (5) other factors over which we have little or no control.
Taking advice from known stock shorters is like showing a pickpocket where you keep your money!!!!!!!!

Bullpen Stocks!

,
,
[chart]www.fotothing.com/p

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.